CHEMOPREVENTION FOR COLORECTAL-CARCINOMA

Citation
Mj. Kahn et Dg. Morrison, CHEMOPREVENTION FOR COLORECTAL-CARCINOMA, Hematology/oncology clinics of North America, 11(4), 1997, pp. 779
Citations number
95
Categorie Soggetti
Oncology,Hematology
ISSN journal
08898588
Volume
11
Issue
4
Year of publication
1997
Database
ISI
SICI code
0889-8588(1997)11:4<779:CFC>2.0.ZU;2-K
Abstract
The goal of chemoprevention is to modify risk factors that contribute to the development of cancer before the neoplastic process can be comp leted. Chemoprevention for colorectal carcinoma has focused on several groups of drugs that act via different mechanisms. Aspirin and non-st eroidal anti-inflammatory drugs may prevent colorectal carcinoma by in hibiting prostaglandin synthesis, specifically by inhibiting the enzym e cyclooxygenase-2. Fiber may reduce the risk of colorectal carcinoma by increasing stool bulk, decreasing bowel transport time of potential carcinogens, or by binding to bile acids or other carcinogens. Calciu m may be chemoprotective by affecting cellular differentiation and/or proliferation. The literature evaluating chemoprevention for colorecta l carcinoma is reviewed here.